首页 > 最新文献

Ethiopian Medical Journal最新文献

英文 中文
Synovial sarcoma. 滑膜肉瘤。
Q3 Medicine Pub Date : 2020-02-10 DOI: 10.32388/3fa77s
Tadele Melese, Yirgu G/Hiwot, J. Schneider
Here we report a rare variety of soft tissue tumor, vulvar synovial sarcoma, arise on 21 years old girl which was managed with local resection.
我们在此报告一例罕见的软组织肿瘤,外阴滑膜肉瘤,发生于一名21岁的女孩,经局部切除治疗。
{"title":"Synovial sarcoma.","authors":"Tadele Melese, Yirgu G/Hiwot, J. Schneider","doi":"10.32388/3fa77s","DOIUrl":"https://doi.org/10.32388/3fa77s","url":null,"abstract":"Here we report a rare variety of soft tissue tumor, vulvar synovial sarcoma, arise on 21 years old girl which was managed with local resection.","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41918264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ainhum. Ainhum。
Q3 Medicine Pub Date : 2020-02-07 DOI: 10.32388/b8tuy6
R. Chandra
{"title":"Ainhum.","authors":"R. Chandra","doi":"10.32388/b8tuy6","DOIUrl":"https://doi.org/10.32388/b8tuy6","url":null,"abstract":"","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46287406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnitude of diabetic retinopathy in newly diagnosed type 2 diabetes patients in Menelik II Hospital, Addis Ababa 亚的斯亚贝巴Menelik II医院新诊断的2型糖尿病患者的糖尿病视网膜病变程度
Q3 Medicine Pub Date : 2019-03-18 DOI: 10.21203/rs.2.451/v1
Rebecca Getachew Wodajo, Dereje Negussie Woyessa, Bezawit Gezahegn Shiferaw
Background: Diabetes mellitus (DM) is one of the most common non-communicable diseases with an increasing incidence worldwide. Diabetic retinopathy (DR), one of the chronic micro vascular complications, is a major global cause of total blindness. As the global prevalence of diabetes increases, so will the numbers of people with diabetic retinopathy. Hence, this study aims to determine the magnitude and severity of DR in newly diagnosed type 2 DM patients in Menelik II Hospital. Method: institutional based cross sectional study was conducted on newly diagnosed Type 2 DM patients. Data were analyzed using Statistical Package for Social Science (SPSS) 20 version computer software. Result: A total of 111 patients with newly diagnosed type II diabetes participated in this study. The female to male ration was 1: 1.84. The mean age of study participants was 50.5 (± 10.6years) with a range of 30-70 years. Majority of respondents (47.7%) completed secondary school while 18.0% were unable to read and write. The average BMI of participants was 25.0 ± 3.6kg/m2, 37 (33.3%) were overweight, 11(9.9%) were obese. Average FBS at diagnosis was 265.25 (0±99.4 mg/dl) for all patients and about 24.3% of the total study population had hypertension. Diabetic retinopathy was detected in 24 (21.6%) patients out of whom 7(29.16%) had mild NPDR, 8 (33.33%) moderate NPDR 5(20.8%)severe NPDR (20.8%) and 4 (16.7%)PDR . Conclusion: The prevalence of diabetic retinopathy at time of diagnosis among type II diabetes showed 21.6%. This high number of undiagnosed DR indicate early and regular screening for diabetic retinopathy among diabetic patients and more aggressive management of modifiable risk factors could reduce the numbers of people who develop vision-threatening retinopathy.
背景:糖尿病(DM)是世界范围内发病率不断上升的最常见非传染性疾病之一。糖尿病视网膜病变(DR)是一种慢性微血管并发症,是全球范围内导致全盲的主要原因之一。随着全球糖尿病患病率的增加,糖尿病视网膜病变患者的数量也将增加。因此,本研究旨在确定Menelik II医院新诊断的2型糖尿病患者DR的程度和严重程度。方法:对新诊断的2型糖尿病患者进行基于机构的横断面研究。采用SPSS 20版计算机软件对数据进行分析。结果:共有111例新诊断的2型糖尿病患者参与了本研究。男女比例为1:1 .84。研究参与者的平均年龄为50.5岁(±10.6岁),年龄范围为30-70岁。大多数受访者(47.7%)完成中学教育,而18.0%不会读写。参与者的平均BMI为25.0±3.6kg/m2,超重37人(33.3%),肥胖11人(9.9%)。所有患者诊断时的平均FBS为265.25(0±99.4 mg/dl),约24.3%的研究人群患有高血压。糖尿病视网膜病变24例(21.6%),其中轻度NPDR 7例(29.16%),中度NPDR 8例(33.33%),重度NPDR 5例(20.8%),重度PDR 4例(16.7%)。结论:2型糖尿病患者诊断时糖尿病视网膜病变患病率为21.6%。大量未确诊的糖尿病视网膜病变表明,糖尿病患者早期和定期筛查糖尿病视网膜病变,并对可改变的危险因素进行更积极的管理,可以减少患视力威胁视网膜病变的人数。
{"title":"Magnitude of diabetic retinopathy in newly diagnosed type 2 diabetes patients in Menelik II Hospital, Addis Ababa","authors":"Rebecca Getachew Wodajo, Dereje Negussie Woyessa, Bezawit Gezahegn Shiferaw","doi":"10.21203/rs.2.451/v1","DOIUrl":"https://doi.org/10.21203/rs.2.451/v1","url":null,"abstract":"\u0000 Background: Diabetes mellitus (DM) is one of the most common non-communicable diseases with an increasing incidence worldwide. Diabetic retinopathy (DR), one of the chronic micro vascular complications, is a major global cause of total blindness. As the global prevalence of diabetes increases, so will the numbers of people with diabetic retinopathy. Hence, this study aims to determine the magnitude and severity of DR in newly diagnosed type 2 DM patients in Menelik II Hospital. Method: institutional based cross sectional study was conducted on newly diagnosed Type 2 DM patients. Data were analyzed using Statistical Package for Social Science (SPSS) 20 version computer software. Result: A total of 111 patients with newly diagnosed type II diabetes participated in this study. The female to male ration was 1: 1.84. The mean age of study participants was 50.5 (± 10.6years) with a range of 30-70 years. Majority of respondents (47.7%) completed secondary school while 18.0% were unable to read and write. The average BMI of participants was 25.0 ± 3.6kg/m2, 37 (33.3%) were overweight, 11(9.9%) were obese. Average FBS at diagnosis was 265.25 (0±99.4 mg/dl) for all patients and about 24.3% of the total study population had hypertension. Diabetic retinopathy was detected in 24 (21.6%) patients out of whom 7(29.16%) had mild NPDR, 8 (33.33%) moderate NPDR 5(20.8%)severe NPDR (20.8%) and 4 (16.7%)PDR . Conclusion: The prevalence of diabetic retinopathy at time of diagnosis among type II diabetes showed 21.6%. This high number of undiagnosed DR indicate early and regular screening for diabetic retinopathy among diabetic patients and more aggressive management of modifiable risk factors could reduce the numbers of people who develop vision-threatening retinopathy.","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44172738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
CURRENT STATUS OF CLINICAL TRIALS IN ETHIOPIA:HOW MUCH IS DONE? 埃塞俄比亚临床试验的现状:做了多少?
Q3 Medicine Pub Date : 2018-03-09 DOI: 10.7892/BORIS.123938
B. T. Deressa, D. Rauch, E. Badra, M. Glatzer, B. Jeremic, K. Lössl, N. Cihoric
Introduction:  Clinical trials are a cornerstone of modern evidence based medicine. They are an important step in discovering new treatments for certain diseases as well as new ways to detect, diagnose, and reduce the risk of disease. They also highly support the clinical practice by generating local evidence. The aim of this study is to evaluate the status and trend of clinical trials in Ethiopia from international trial registries. Material and Methods:  We have searched WHO International Clinical Trial Registry Platform (WHO ICTRP) for all trials with at least one recruitment center in Ethiopia. The results were exported in XML format and a rational database was formed. Results:  Up to November 15,2016; 145 clinical trials were found to be registered from Ethiopia. Majority of trials were design on infectious disease (n = 87, 60%) and the rest were done on NCD. The five most common infectious disease evaluated were Malaria (n=15; 10%), Tuberculosis (n=13; 9%), trachoma (n=12; 8%), HIV (n=11; 8%) and helminthiasis (n=6; 4%). The most common NCD was malnutrition (n = 19; 13%) and only one trial was on cancer, namely Wilms Tumor (1%). London School of Hygiene and Tropical Medicine was the sponsor with the highest number of registered trials (n=8, 6% of all trials), followed by Columbia, Jimma and Ghent University with 5 (3%) trials each. Conclusions: The clinical trials done in Ethiopia are very much limited in number and variety. To improve the situation the government, industry, academic institutions, patient advocacy groups, professional societies and other organizations should work together.
临床试验是现代循证医学的基石。它们是发现某些疾病的新治疗方法以及发现、诊断和降低疾病风险的新方法的重要一步。他们还通过产生当地证据高度支持临床实践。本研究的目的是从国际试验注册中评估埃塞俄比亚临床试验的现状和趋势。材料和方法:我们检索了世卫组织国际临床试验注册平台(WHO ICTRP)中在埃塞俄比亚至少有一个招募中心的所有试验。结果以XML格式导出,并形成一个合理的数据库。截止2016年11月15日;145项临床试验在埃塞俄比亚注册。大多数试验设计用于传染病(n = 87, 60%),其余试验设计用于非传染性疾病。评估的五种最常见传染病是疟疾(n=15;10%),肺结核(n=13;9%),沙眼(n=12;8%),艾滋病毒(n=11;8%)和寄生虫病(n=6;4%)。最常见的非传染性疾病是营养不良(n = 19;13%),只有一项试验是针对癌症的,即Wilms肿瘤(1%)。伦敦卫生与热带医学学院是注册试验数量最多的赞助机构(n= 8,6 %),其次是哥伦比亚大学、吉玛大学和根特大学,各有5项试验(3%)。结论:在埃塞俄比亚进行的临床试验在数量和种类上都非常有限。为了改善这种状况,政府、行业、学术机构、患者倡导团体、专业协会和其他组织应该共同努力。
{"title":"CURRENT STATUS OF CLINICAL TRIALS IN ETHIOPIA:HOW MUCH IS DONE?","authors":"B. T. Deressa, D. Rauch, E. Badra, M. Glatzer, B. Jeremic, K. Lössl, N. Cihoric","doi":"10.7892/BORIS.123938","DOIUrl":"https://doi.org/10.7892/BORIS.123938","url":null,"abstract":"Introduction:  Clinical trials are a cornerstone of modern evidence based medicine. They are an important step in discovering new treatments for certain diseases as well as new ways to detect, diagnose, and reduce the risk of disease. They also highly support the clinical practice by generating local evidence. The aim of this study is to evaluate the status and trend of clinical trials in Ethiopia from international trial registries. Material and Methods:  We have searched WHO International Clinical Trial Registry Platform (WHO ICTRP) for all trials with at least one recruitment center in Ethiopia. The results were exported in XML format and a rational database was formed. Results:  Up to November 15,2016; 145 clinical trials were found to be registered from Ethiopia. Majority of trials were design on infectious disease (n = 87, 60%) and the rest were done on NCD. The five most common infectious disease evaluated were Malaria (n=15; 10%), Tuberculosis (n=13; 9%), trachoma (n=12; 8%), HIV (n=11; 8%) and helminthiasis (n=6; 4%). The most common NCD was malnutrition (n = 19; 13%) and only one trial was on cancer, namely Wilms Tumor (1%). London School of Hygiene and Tropical Medicine was the sponsor with the highest number of registered trials (n=8, 6% of all trials), followed by Columbia, Jimma and Ghent University with 5 (3%) trials each. Conclusions: The clinical trials done in Ethiopia are very much limited in number and variety. To improve the situation the government, industry, academic institutions, patient advocacy groups, professional societies and other organizations should work together.","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41902384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Ethiopia Schistosomiasis and Soil-Transmitted Helminthes Control Programme: Progress and Prospects. 埃塞俄比亚血吸虫病和土壤传播蠕虫控制规划:进展与展望。
Q3 Medicine Pub Date : 2017-08-14 DOI: 10.4172/2332-0877-C3-044
N. Negussu, B. Mengistu, B. Kebede, Kebede Deribe, Ephrem Ejigu, Gemechu Tadesse, K. Mekete, Mesfin Sileshi
Schistosomiasis and soil-transmitted helminthes are among seventeen WHO prioritized neglected tropical diseases that infect humans. These parasitic infections can be treated using single-dose and safe drugs. Ethiopia successfully mapped the distribution of these infections nationwide. According to the mapping there are an estimated 37.3 million people living in schistosomiasis endemic areas, and 79 million in schistosomiasis and soil-transmitted helminthes endemic areas. The Federal Ministry of Health successfully scaled up Schistosomiasis and schistosomiasis and soil-transmitted helminthes intervention in endemic areas and treated over 19 million individuals in 2015. The Ministry of Health has made a huge effort to establish neglected tropical diseases, including schistosomiasis and soil-transmitted helminthes program in the health system which helped to map majority of the woredas and initiate nationwide intervention. The National control programme is designed to achieve elimination for those diseases as a major public health problem by 2020 and aim to attain transmission break by 2025. The programme focuses on reaching those school-aged children who are not attending school, integration between neglected tropical diseases programme, and further collaboration with the WASH actors.
血吸虫病和土壤传播的蠕虫是世界卫生组织优先考虑的17种感染人类的热带疾病之一。这些寄生虫感染可以使用单剂量和安全的药物进行治疗。埃塞俄比亚成功地绘制了这些感染在全国范围内的分布图。根据该地图,估计有3730万人生活在血吸虫病流行区,7900万人居住在血吸虫病和土壤传播蠕虫流行区。2015年,联邦卫生部在血吸虫病流行地区成功扩大了血吸虫病和土壤传播蠕虫的干预力度,治疗了1900多万人。卫生部为建立被忽视的热带疾病做出了巨大努力,包括卫生系统中的血吸虫病和土壤传播蠕虫计划,该计划帮助绘制了大多数世界的地图,并启动了全国性干预。国家控制计划旨在到2020年消除这些作为主要公共卫生问题的疾病,并旨在到2025年实现传播中断。该方案的重点是帮助那些失学的学龄儿童,将被忽视的热带疾病方案纳入其中,并与讲卫生运动行动者进一步合作。
{"title":"Ethiopia Schistosomiasis and Soil-Transmitted Helminthes Control Programme: Progress and Prospects.","authors":"N. Negussu, B. Mengistu, B. Kebede, Kebede Deribe, Ephrem Ejigu, Gemechu Tadesse, K. Mekete, Mesfin Sileshi","doi":"10.4172/2332-0877-C3-044","DOIUrl":"https://doi.org/10.4172/2332-0877-C3-044","url":null,"abstract":"Schistosomiasis and soil-transmitted helminthes are among seventeen WHO prioritized neglected tropical diseases that infect humans. These parasitic infections can be treated using single-dose and safe drugs. Ethiopia successfully mapped the distribution of these infections nationwide. According to the mapping there are an estimated 37.3 million people living in schistosomiasis endemic areas, and 79 million in schistosomiasis and soil-transmitted helminthes endemic areas. The Federal Ministry of Health successfully scaled up Schistosomiasis and schistosomiasis and soil-transmitted helminthes intervention in endemic areas and treated over 19 million individuals in 2015. The Ministry of Health has made a huge effort to establish neglected tropical diseases, including schistosomiasis and soil-transmitted helminthes program in the health system which helped to map majority of the woredas and initiate nationwide intervention. The National control programme is designed to achieve elimination for those diseases as a major public health problem by 2020 and aim to attain transmission break by 2025. The programme focuses on reaching those school-aged children who are not attending school, integration between neglected tropical diseases programme, and further collaboration with the WASH actors.","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41480269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 64
GUILLAIN-BARRE SYNDROME ASSOCIATED WITH PULMONARY TUBERCULOSIS: 格林-巴利综合征与肺结核:
Q3 Medicine Pub Date : 2017-03-15 DOI: 10.4021/jmc1288w
D. K. Huluka, M. A. Abdu, T. Gebremariam, A. Binegdie, Getahun Mengistu Takele
Guillain-Barre Syndrome is one of the causes of neuromuscular paralysis. Majority have a preceding viral or bacterial infection. We report a case of 25-year-old man who presented with clinical features of Guillain-Barre Syndrome and was found to have pulmonary tuberculosis. Only a few similar cases were reported hitherto. We want to bring the possible association between Guillain-Barre Syndrome and tuberculosis to the attention of clinicians.
格林-巴利综合征是导致神经肌肉麻痹的原因之一。大多数之前有病毒或细菌感染。我们报告一个25岁的男子谁提出了临床特征的格林-巴利综合征,并被发现有肺结核。到目前为止,只有少数类似的病例被报道。我们希望引起临床医生对格林-巴利综合征和结核病之间可能存在的联系的注意。
{"title":"GUILLAIN-BARRE SYNDROME ASSOCIATED WITH PULMONARY TUBERCULOSIS:","authors":"D. K. Huluka, M. A. Abdu, T. Gebremariam, A. Binegdie, Getahun Mengistu Takele","doi":"10.4021/jmc1288w","DOIUrl":"https://doi.org/10.4021/jmc1288w","url":null,"abstract":"Guillain-Barre Syndrome is one of the causes of neuromuscular paralysis. Majority have a preceding viral or bacterial infection. We report a case of 25-year-old man who presented with clinical features of Guillain-Barre Syndrome and was found to have pulmonary tuberculosis. Only a few similar cases were reported hitherto. We want to bring the possible association between Guillain-Barre Syndrome and tuberculosis to the attention of clinicians.","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41506075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
CLINICAL ASSESSMENT OF CARDIOVASCULAR DISEASE ASSOCIATED RISK FACTORS IN JIMMATOWN, SOUTHWEST ETHIOPIA; A COMMUNITY BASED CROSS – SECTIONAL STUDY. 埃塞俄比亚西南部吉马敦心血管疾病相关危险因素的临床评估基于社区的横断面研究。
Q3 Medicine Pub Date : 2017-01-01
Hailemichael Desalegn, Sintayehu Fekadu, Amare Deribew

Introduction: Cardiovascular disease has been identified as emerging epidemic in developing world and Sub-saharan Africa. The prevalence of risk factors associated with cardiovascular disease is not clearly established in our country. We conducted this study to determine the prevalence of cardiovascular disease associated risk factors in Jimma town.

Methods: A cross-sectional study was conducted in sampled adults in Jimma town. Multi-stage sampling was used by combining simple random sampling to select kebeles of Jimma town and then systematic random sampling to select the house hold .An individual was selected with a lottery method if there were more than one adult in the house hold who fulfills inclusion criteria. Data were collected using the World Health Organization standardized structured questionnaire on cardiovascular risk assessment for developing countries. The study variables included anthropometric measurements, demographic information and behavioral risk factors. The data variables were computed using SPSS version 20.

Results: Majority (70.9%) of the respondents have one or more of the seven cardiovascular disease risk factors assessed. Nearly one forth (23.8%) of the study participants were hypertensive, 6.2% were known diabetes and the prevalence of smoking was 11.8% among males 2% among females. The prevalence of overweight/obesity was 26.8 %.

Conclusion: Majority were found to have at least one of the risk factors for cardiovascular disease. Hypertension and diabetes mellitus were the most common. Screening programs, health education and awareness creation are recommended to prevent the development of the disease. Large scale prospective study with laboratory data will help to further analyze and strengthen the results for policy makers.

导言:心血管疾病已被确定为发展中国家和撒哈拉以南非洲新出现的流行病。与心血管疾病相关的危险因素的流行率在我国尚未明确确定。我们进行这项研究是为了确定吉马镇心血管疾病流行的相关危险因素。方法:采用横断面调查方法对吉马镇成人进行抽样调查。采用简单随机抽样和系统随机抽样相结合的多阶段抽样方法对吉马镇的kebeles进行抽样,然后对户型进行系统随机抽样,如果户型中有一个以上符合入选标准的成年人,则采用摇号法对个体进行抽样。使用世界卫生组织关于发展中国家心血管风险评估的标准化结构化问卷收集数据。研究变量包括人体测量、人口统计信息和行为风险因素。数据变量采用SPSS version 20进行计算。结果:大多数(70.9%)的受访者在评估的七种心血管疾病危险因素中有一种或多种。近四分之一(23.8%)的研究参与者患有高血压,6.2%患有已知的糖尿病,吸烟患病率在男性中为11.8%,在女性中为2%。超重/肥胖患病率为26.8%。结论:大多数人至少有一种心血管疾病的危险因素。高血压和糖尿病是最常见的。建议进行筛查、健康教育和提高认识,以预防该病的发展。利用实验室数据进行大规模前瞻性研究,将有助于进一步分析和强化研究结果,为决策者提供参考。
{"title":"CLINICAL ASSESSMENT OF CARDIOVASCULAR DISEASE ASSOCIATED RISK FACTORS IN JIMMATOWN, SOUTHWEST ETHIOPIA; A COMMUNITY BASED CROSS – SECTIONAL STUDY.","authors":"Hailemichael Desalegn,&nbsp;Sintayehu Fekadu,&nbsp;Amare Deribew","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Cardiovascular disease has been identified as emerging epidemic in developing world and Sub-saharan Africa. The prevalence of risk factors associated with cardiovascular disease is not clearly established in our country. We conducted this study to determine the prevalence of cardiovascular disease associated risk factors in Jimma town.</p><p><strong>Methods: </strong>A cross-sectional study was conducted in sampled adults in Jimma town. Multi-stage sampling was used by combining simple random sampling to select kebeles of Jimma town and then systematic random sampling to select the house hold .An individual was selected with a lottery method if there were more than one adult in the house hold who fulfills inclusion criteria. Data were collected using the World Health Organization standardized structured questionnaire on cardiovascular risk assessment for developing countries. The study variables included anthropometric measurements, demographic information and behavioral risk factors. The data variables were computed using SPSS version 20.</p><p><strong>Results: </strong>Majority (70.9%) of the respondents have one or more of the seven cardiovascular disease risk factors assessed. Nearly one forth (23.8%) of the study participants were hypertensive, 6.2% were known diabetes and the prevalence of smoking was 11.8% among males 2% among females. The prevalence of overweight/obesity was 26.8 %.</p><p><strong>Conclusion: </strong>Majority were found to have at least one of the risk factors for cardiovascular disease. Hypertension and diabetes mellitus were the most common. Screening programs, health education and awareness creation are recommended to prevent the development of the disease. Large scale prospective study with laboratory data will help to further analyze and strengthen the results for policy makers.</p>","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35620536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FACTORS ASSOCIATED WITH TREATMENT OUTCOME OF PEDIATRIC CANCERPATIENTS ADMITTED WITH FEBRILE NEUTROPENIA IN TIKURANBESSA SPECIALIZED TEACHING HOSPITAL, ADDIS ABABA, ETHIOPIA. 埃塞俄比亚亚的斯亚贝巴tikuranbessa专科教学医院收治的发热性中性粒细胞减少症儿童癌症患者治疗结果的相关因素
Q3 Medicine Pub Date : 2017-01-01
Selamawit Assefa, Tinsae Alemayehu, Workeabeba Abebe

Background: Cancer treatment is associated with variable degrees of myelosupression. Infection is often a life-threatening complication of chemotherapy-induced neutropenia, and it is also considered an oncologic emergency. Febrile neutropenia is a common, costly and potentially fatal complication in oncology.

Objective: To assess factors affecting treatment outcome of cancer patients with chemotherapy induced febrile neutropenia.

Method: We conducted a review of records of pediatric patients hospitalized and treated for chemotherapy-induced febrile neutropenia from January 1, 2013 to December 31, 2013 and met the selection criteria.

Result: A total of 60 patients (36 males and 24 females) fulfilled the selection criteria. Twelve of them died while in hospital. The mean (SD) age of patients who died was 4.78 (±2.48) years and the mean (SD) hospital stay before death was 20.2 (±5.26) days. Ten children had hematologic malignancy and two had a solid tumor. Ten of the 12 patients had an absolute neutrophil count of less than 100/mm3 (p=0.008, OR=20.3) and a platelet count of less than 50,000/mm3. Six of the 10 children (10%) had sepsis. Patients with profound neutropenia, platelet count of less than 50,000 and sepsis were more likely to die (P=0.048, OR=7).

Conclusion: The result of this study showed that absolute neutrophil count of less than 100/mm3, platelet count of less than 50,000/mm3 and a diagnosis of sepsis were factors affecting outcome patients with febrile neutropenia. Careful evaluation of these factors and assessing severity of patients’ clinical condition at time of admission can be useful for triaging children with febrile neutropenia.

背景:癌症治疗与不同程度的骨髓抑制有关。感染通常是化疗引起的中性粒细胞减少症的危及生命的并发症,它也被认为是肿瘤急症。发热性中性粒细胞减少症是肿瘤学中一种常见、昂贵且可能致命的并发症。目的:探讨影响化疗所致发热性中性粒细胞减少患者治疗效果的因素。方法:回顾2013年1月1日至2013年12月31日住院治疗的化疗致发热性中性粒细胞减少症患儿的记录,符合选择标准。结果:60例患者(男36例,女24例)符合入选标准。其中12人在医院死亡。死亡患者的平均(SD)年龄为4.78(±2.48)岁,死亡前平均住院时间(SD)为20.2(±5.26)天。10名儿童有血液恶性肿瘤,2名有实体瘤。12例患者中有10例绝对中性粒细胞计数小于100/mm3 (p=0.008, OR=20.3),血小板计数小于50,000/mm3。10名儿童中有6名(10%)患有败血症。重度中性粒细胞减少、血小板计数小于5万、脓毒症患者死亡的可能性更高(P=0.048, OR=7)。结论:本研究结果显示,中性粒细胞绝对计数小于100/mm3、血小板计数小于5万/mm3和败血症诊断是影响发热性中性粒细胞减少患者预后的因素。在入院时仔细评估这些因素和评估患者临床状况的严重程度,可用于分诊发热性中性粒细胞减少症儿童。
{"title":"FACTORS ASSOCIATED WITH TREATMENT OUTCOME OF PEDIATRIC CANCERPATIENTS ADMITTED WITH FEBRILE NEUTROPENIA IN TIKURANBESSA SPECIALIZED TEACHING HOSPITAL, ADDIS ABABA, ETHIOPIA.","authors":"Selamawit Assefa,&nbsp;Tinsae Alemayehu,&nbsp;Workeabeba Abebe","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Cancer treatment is associated with variable degrees of myelosupression. Infection is often a life-threatening complication of chemotherapy-induced neutropenia, and it is also considered an oncologic emergency. Febrile neutropenia is a common, costly and potentially fatal complication in oncology.</p><p><strong>Objective: </strong>To assess factors affecting treatment outcome of cancer patients with chemotherapy induced febrile neutropenia.</p><p><strong>Method: </strong>We conducted a review of records of pediatric patients hospitalized and treated for chemotherapy-induced febrile neutropenia from January 1, 2013 to December 31, 2013 and met the selection criteria.</p><p><strong>Result: </strong>A total of 60 patients (36 males and 24 females) fulfilled the selection criteria. Twelve of them died while in hospital. The mean (SD) age of patients who died was 4.78 (±2.48) years and the mean (SD) hospital stay before death was 20.2 (±5.26) days. Ten children had hematologic malignancy and two had a solid tumor. Ten of the 12 patients had an absolute neutrophil count of less than 100/mm3 (p=0.008, OR=20.3) and a platelet count of less than 50,000/mm3. Six of the 10 children (10%) had sepsis. Patients with profound neutropenia, platelet count of less than 50,000 and sepsis were more likely to die (P=0.048, OR=7).</p><p><strong>Conclusion: </strong>The result of this study showed that absolute neutrophil count of less than 100/mm3, platelet count of less than 50,000/mm3 and a diagnosis of sepsis were factors affecting outcome patients with febrile neutropenia. Careful evaluation of these factors and assessing severity of patients’ clinical condition at time of admission can be useful for triaging children with febrile neutropenia.</p>","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35620538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elimination of Guinea Worm Disease in Ethiopia; Current Status of the Disease's, Eradication Strategies and Challenges to the End Game. 在埃塞俄比亚消除几内亚蠕虫病;疾病现状、根除战略和终局挑战。
Q3 Medicine Pub Date : 2017-01-01
Habtamu Bedimo Beyene, Abyot Bekele, Amanu Shifara, Yehenew A Ebstie, Zelalem Desalegn, Zeyede Kebede, Abate Mulugeta, Kebede Deribe, Zerihun Tadesse, Tamrat Abebe, Biruck Kebede, Getaneh Abrha, Daddi Jima

Dracunculiasis, also named Guinea Worm Disease (GWD), is one of the Neglected Tropical Diseases (NTDs) caused by a parasitic nematode known as Dracunculus medinensis and has been known since antiquity as 'fiery serpent' from Israelites. It is transmitted to humans via drinking contaminated water containing infective copepods. Given, its feasibility for eradication, the Guinea Worm Eradication Program (GWEP) was launched in 1980 with the aim of eradicating the disease. Since its inception, GWEP has made an extraordinary progress in interrupting transmission. Globally, the number of reported cases reduced from 3.5 million in 20 countries in 1986 to only 22 cases in 2015 from only four countries namely South Sudan, Mali, Chad and Ethiopia. Since Mali has interrupted transmission of GWD in 2016, currently, the disease remains endemic in only three sub-Saharan African countries namely, South Sudan, Chad and Ethiopia. Each endemic country has its own national Guinea Worm Eradication Program. In Ethiopia, the Ethiopian Dracunculiasis Eradication Program (EDEP) which was established in 1993 has made remarkable move towards interruption of disease transmission and now the endgame is fast approaching. The EDEP with support mainly from The Carter Center, WHO, and UNICEF has reduced GWD by more than 99% from 1994 to 2015. In 2015, only 3 indigenous cases in humans and 14 in animals (13 in dogs and 1 in baboon) were reported. In 2016, 3 human cases, 14 dogs and 2 baboon infections were reported.. Refugee influx from the Republic of South Sudan (RSS), increased animal infections with unknown role in transmission of Dracunculiasis, the presence of hard to reach communities and lack of safe water sources in remote non-village areas remain among important challenges at this final stage of GWD eradication in Ethiopia. This paper reviews progress made towards Guinea Worm Eradication with a focus on the experience of the Ethiopian Dracunculiasis Eradication Program (EDEP), and intervention strategies that need further intensification to realize the endgame. Eradication strategies encompassing community education for behavioral change including raising awareness towards cash reward for reporting Guniea Worm Disease (GWD) and animal infection, case containment, surveillance systems, provision of safe water supply, and ABATE chemical application are discussed. It also summarizes challenges the end game faces and recommendations to strengthen the eradication effort.

麦地那龙线虫病(Dracunculiasis)又称几内亚蠕虫病(GWD),是被忽视的热带病(NTD)之一,由一种名为麦地那龙线虫(Dracunculus medinensis)的寄生线虫引起,自古以来就被以色列人称为 "火蛇"。它通过饮用含有感染性桡足类的污染水传播给人类。鉴于根除这种疾病的可行性,1980 年启动了几内亚蠕虫根除计划(GWEP),旨在根除这种疾病。自启动以来,根除几内亚蠕虫计划在阻断传播方面取得了非凡的进展。在全球范围内,报告病例数从 1986 年 20 个国家的 350 万例减少到 2015 年仅四个国家(即南苏丹、马里、乍得和埃塞俄比亚)的 22 例。由于马里在 2016 年中断了 GWD 的传播,目前该疾病仅在南苏丹、乍得和埃塞俄比亚三个撒哈拉以南非洲国家流行。每个流行国都有自己的国家几内亚蠕虫根除计划。在埃塞俄比亚,埃塞俄比亚根除麦地那龙线虫病计划(EDEP)成立于 1993 年,该计划在阻断疾病传播方面取得了显著进展,目前已接近尾声。在主要由卡特中心、世卫组织和联合国儿童基金会提供的支持下,EDEP 在 1994 年至 2015 年期间已将 GWD 减少了 99% 以上。2015 年,仅报告了 3 例人类本地病例和 14 例动物病例(13 例狗病例和 1 例狒狒病例)。2016 年,报告了 3 例人类感染病例、14 例狗感染病例和 2 例狒狒感染病例。来自南苏丹共和国(RSS)的难民涌入、在麦地那龙线虫病传播中作用不明的动物感染增加、难以到达的社区的存在以及偏远非村庄地区安全水源的缺乏仍然是埃塞俄比亚根除麦地那龙线虫病最后阶段面临的重要挑战。本文回顾了埃塞俄比亚根除麦地那龙线虫病计划(EDEP)在根除麦地那龙线虫病方面取得的进展,以及为实现最终目标而需要进一步加强的干预战略。本报告讨论了根除战略,包括改变行为的社区教育(包括提高对报告古尼埃阿蠕虫病(GWD)和动物感染的现金奖励的认识)、病例控制、监测系统、提供安全供水和 ABATE 化学应用。报告还总结了最终目标面临的挑战以及加强根除工作的建议。
{"title":"Elimination of Guinea Worm Disease in Ethiopia; Current Status of the Disease's, Eradication Strategies and Challenges to the End Game.","authors":"Habtamu Bedimo Beyene, Abyot Bekele, Amanu Shifara, Yehenew A Ebstie, Zelalem Desalegn, Zeyede Kebede, Abate Mulugeta, Kebede Deribe, Zerihun Tadesse, Tamrat Abebe, Biruck Kebede, Getaneh Abrha, Daddi Jima","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Dracunculiasis, also named Guinea Worm Disease (GWD), is one of the Neglected Tropical Diseases (NTDs) caused by a parasitic nematode known as Dracunculus medinensis and has been known since antiquity as 'fiery serpent' from Israelites. It is transmitted to humans via drinking contaminated water containing infective copepods. Given, its feasibility for eradication, the Guinea Worm Eradication Program (GWEP) was launched in 1980 with the aim of eradicating the disease. Since its inception, GWEP has made an extraordinary progress in interrupting transmission. Globally, the number of reported cases reduced from 3.5 million in 20 countries in 1986 to only 22 cases in 2015 from only four countries namely South Sudan, Mali, Chad and Ethiopia. Since Mali has interrupted transmission of GWD in 2016, currently, the disease remains endemic in only three sub-Saharan African countries namely, South Sudan, Chad and Ethiopia. Each endemic country has its own national Guinea Worm Eradication Program. In Ethiopia, the Ethiopian Dracunculiasis Eradication Program (EDEP) which was established in 1993 has made remarkable move towards interruption of disease transmission and now the endgame is fast approaching. The EDEP with support mainly from The Carter Center, WHO, and UNICEF has reduced GWD by more than 99% from 1994 to 2015. In 2015, only 3 indigenous cases in humans and 14 in animals (13 in dogs and 1 in baboon) were reported. In 2016, 3 human cases, 14 dogs and 2 baboon infections were reported.. Refugee influx from the Republic of South Sudan (RSS), increased animal infections with unknown role in transmission of Dracunculiasis, the presence of hard to reach communities and lack of safe water sources in remote non-village areas remain among important challenges at this final stage of GWD eradication in Ethiopia. This paper reviews progress made towards Guinea Worm Eradication with a focus on the experience of the Ethiopian Dracunculiasis Eradication Program (EDEP), and intervention strategies that need further intensification to realize the endgame. Eradication strategies encompassing community education for behavioral change including raising awareness towards cash reward for reporting Guniea Worm Disease (GWD) and animal infection, case containment, surveillance systems, provision of safe water supply, and ABATE chemical application are discussed. It also summarizes challenges the end game faces and recommendations to strengthen the eradication effort.</p>","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582630/pdf/emss-73811.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9947618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RARE CO-EXISTENCE OF CORONARY ANOMALIES: ANOMALY OF ORIGIN AND DISTRIBUTION TOGETHER WITH ANOMALY OF INTRINSIC CORONARY ARTERY ANOMALY. 罕见的冠状动脉异常共存:起源分布异常与内禀冠状动脉异常并存。
Q3 Medicine Pub Date : 2017-01-01
Abraha Hailu, Diana Chin, Carmine Musto, Rosario Fiorilli, Roberto Violini

We describe a 63 year old Romanian female patient admitted to our institution with complaints of typical anginaand a diagnosis of non ST-elevation myocardial infarction. Coronary arteriography unveiled anomalous origin ofa left circumflex coronary artery from the right coronary sinus of Valsalva near the right coronary ostium and ahyperdominant left anterior descending coronary artery giving off a posterior descending coronary artery withsmall distal-posterolateral left ventricular branch. The co-existence of a left circumflex coronary artery originatingectopically from the right sinus of Valsalva together with a posterior descending coronary artery originatingfrom the distal end of the anterior descending artery is important to keep in mind especially by those doing coronaryangiography in the cardiac catheterization laboratory.

我们描述了一位63岁的罗马尼亚女性患者,以典型的心绞痛和非st段抬高型心肌梗死的诊断入住我们的机构。冠状动脉造影显示左旋冠状动脉异常起源于右冠状动脉口附近的右Valsalva冠状动脉窦,左前降支异常,并发出后降支,左心室远后外侧分支小。左旋冠状动脉与起源于前降支远端的后降支同时存在是很重要的,特别是在心导管实验室做冠状动脉造影的人要记住。
{"title":"RARE CO-EXISTENCE OF CORONARY ANOMALIES: ANOMALY OF ORIGIN AND DISTRIBUTION TOGETHER WITH ANOMALY OF INTRINSIC CORONARY ARTERY ANOMALY.","authors":"Abraha Hailu,&nbsp;Diana Chin,&nbsp;Carmine Musto,&nbsp;Rosario Fiorilli,&nbsp;Roberto Violini","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We describe a 63 year old Romanian female patient admitted to our institution with complaints of typical angina\u0000and a diagnosis of non ST-elevation myocardial infarction. Coronary arteriography unveiled anomalous origin of\u0000a left circumflex coronary artery from the right coronary sinus of Valsalva near the right coronary ostium and a\u0000hyperdominant left anterior descending coronary artery giving off a posterior descending coronary artery with\u0000small distal-posterolateral left ventricular branch. The co-existence of a left circumflex coronary artery originating\u0000ectopically from the right sinus of Valsalva together with a posterior descending coronary artery originating\u0000from the distal end of the anterior descending artery is important to keep in mind especially by those doing coronary\u0000angiography in the cardiac catheterization laboratory.</p>","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35256988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ethiopian Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1